Universal Biosensors, Inc. (ASX:UBI)
Australia · Delayed Price · Currency is AUD 0.0140
0.00 (0.00%)
Feb 13, 2026, 4:25 AM AEST
Universal Biosensors Market Cap
Universal Biosensors has a market cap or net worth of 4.17 million as of June 26, 2026. Its market cap has decreased by -89.23% in one year.
Market Cap
4.17M
Enterprise Value
5.02M
Revenue
5.95M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
Market Cap Chart
Since December 13, 2006, Universal Biosensors's market cap has decreased from 131.91M to 4.17M, a decrease of -96.84%. That is a compound annual growth rate of -16.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 4.17M | -86.67% |
| Dec 31, 2024 | 31.30M | -26.31% |
| Dec 29, 2023 | 42.47M | -10.89% |
| Dec 30, 2022 | 47.66M | -72.92% |
| Dec 31, 2021 | 176.04M | 127.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CleanSpace Holdings | 31.56M |
| Nova Eye Medical | 29.20M |
| Micro-X | 24.06M |
| Memphasys | 19.93M |
| OncoSil Medical | 17.96M |
| Atomo Diagnostics | 15.34M |
| CONNEQT Health | 14.16M |
| ImpediMed | 14.03M |